LON:AOM - Activeops PLC
Executive Summary
ActiveOps PLC is a UK-listed software company, traded on AIM under the ticker LON:AOM, that provides cloud-based workforce management (WFM) and operations optimisation software principally to large contact-centre and back-office operators in financial services, healthcare, and retail. Its market position is that of a focused mid-sized specialist in a fragmented niche rather than a category leader, competing against larger enterprise software vendors and smaller regional players.
The investment case rests on a forward revenue trajectory towards roughly GBP 52.6m and a published analyst target that implies moderate upside from 215p, supported by an ongoing strategic acquisition (Enlighten) intended to accelerate product and geographic reach. The most material near-term scheduled item is the company's full-year results announcement, referenced in its full-year trading update, where reported revenue, recurring subscription metrics, and integration costs from the Enlighten transaction will set the tone for the next twelve months. The primary risk is that the company remains sub-scale relative to well-capitalised competitors, a constraint that issuer filings have themselves flagged.
OPPORTUNISTIC BUY. Conviction Score: 59/100. The view would be upgraded on evidence of sustained double-digit organic ARR growth, demonstrable Enlighten integration synergies, and any disclosure of a large named contract win. The view would be downgraded on a further trading update pointing to decelerating subscriptions, a dilutive capital raise to fund integration, or a disclosed loss of a material enterprise customer.
Thesis break: A full-year results announcement that discloses decelerating recurring revenue growth combined with a further rise in restructuring or integration costs, or a confirmed dilutive equity raise to fund the Enlighten integration, would invalidate the thesis.
Business Model
ActiveOps generates revenue predominantly through recurring SaaS subscriptions, sold on a per-seat or per-module basis to enterprise customers. Contracts are typically multi-year (commonly one to three years), and a substantial majority of group revenue is recurring in nature, which produces the kind of revenue visibility typical of subscription software businesses. The product suite covers workforce scheduling, attendance and absence management, performance analytics, and compliance reporting, with customers drawn from regulated sectors such as financial services, healthcare, and large retail operations where workforce scheduling is mission-critical and subject to audit.
The customer base is concentrated in the United Kingdom and Australia/New Zealand, and the company has historically skewed towards blue-chip enterprise clients that are won through a land-and-expand motion: an initial deployment of a single module (most often scheduling) is followed over time by the adoption of additional modules, which lifts average revenue per customer. The Enlighten acquisition, announced in 2024, is intended to broaden the platform into adjacent operations-management workflows and to extend the customer footprint into the Australian mid-market.
Profitability remains modest. Public commentary references a net margin of 4.41% and a return on equity of 0.01%, which is consistent with a company still in a reinvestment phase rather than a mature cash-generative software business. Restructuring costs of approximately GBP 1.2m were incurred in connection with the Enlighten transaction, indicating that management is actively reshaping the cost base alongside the acquisition. The competitive moat rests on regulatory and integration stickiness within large enterprise customers rather than on technological differentiation, which leaves the business exposed to larger well-capitalised competitors over the longer term.
Financial Snapshot
Recent Catalysts
[November 2024] - ActiveOps announced the acquisition of Enlighten Group Pty Ltd, disclosed via a London Stock Exchange regulatory announcement, intended to accelerate the company's product roadmap and broaden its customer base in Australia and New Zealand. Source: London Stock Exchange regulatory announcement.
[2024 / full-year trading update] - ActiveOps issued a full-year trading update and notice of results confirming that the Enlighten integration was progressing and that approximately GBP 1.2m of restructuring costs had been incurred; the trading update set the expectation for a forthcoming full-year results release. Source: InvestEgate RNS announcement.
[February 2026] - Director Richard John Jeffery purchased 54 shares of ActiveOps stock, an insider transaction disclosed in publicly reported PDMR dealing coverage. The size of the transaction is small in absolute terms but is consistent with continued insider participation in the equity. Source: Public PDMR dealing disclosure as reported by financial news wires.
[2026] - ActiveOps disclosed the sale of WorkiQ trademarks to Microsoft for $10 million, a discrete monetisation event that releases value from a non-core intellectual property asset. Source: Company announcement reported via regulatory news service.
[January 2026] - The ActiveOps share price moved lower by approximately 1.6% in a single session on a day without a disclosed company-specific catalyst, illustrating ongoing share-price sensitivity to general market conditions. Source: Markets Daily market coverage.
Thesis Evaluation
Bull Case (25% weight)
Forecast revenue growth towards GBP 52.6m materialises, the Enlighten integration delivers measurable cross-sell into the ANZ mid-market, and SaaS recurring-revenue metrics expand at a double-digit rate. In that scenario, the shares re-rate towards the published analyst target of 311p within a twelve-month horizon.
Base Case (50% weight)
The company delivers a steady trading update, recurring revenue grows at a high-single-digit to low-double-digit pace, and the Enlighten integration costs prove to be a one-off rather than an ongoing drag. In this more measured outcome the shares drift modestly higher to 245p over twelve months as the market gains confidence in the integration without a full re-rating.
Bear Case (25% weight)
A further trading update points to subscription deceleration, a competitor takes share in the core UK financial-services vertical, or the company is forced into a dilutive equity raise to fund integration or working capital. In that scenario, the shares de-rate to 160p over twelve months, a level below the current price and broadly consistent with the lower end of the 52-week range.
Key Risks
- Sub-scale competitive position: Issuer filings themselves flag the risk of limited financial depth versus larger competitors, which could constrain product investment and pricing power. Estimated probability: 35%. Impact: severe.
- Integration risk from the Enlighten acquisition: Roughly GBP 1.2m of restructuring costs have already been incurred, and there is no public confirmation that the integration is on track to deliver the expected cross-sell and product synergies. Estimated probability: 30%. Impact: moderate.
- Customer concentration in financial services and healthcare: A meaningful share of revenue is tied to regulated UK enterprise customers; the loss of one or two large accounts would have an outsized effect on group ARR. Estimated probability: 20%. Impact: severe.
- Limited liquidity and AIM listing constraints: A small free float on AIM limits institutional accessibility and can magnify share-price moves on negative news flow. Estimated probability: 50%. Impact: moderate.
- Need for further capital: With a return on equity of 0.01% and a thin profitability profile, the company may need to raise additional capital to fund integration or product investment, which would dilute existing holders. Estimated probability: 20%. Impact: severe.
Who Should Own It / Avoid It
Ideal for: a UK small-cap specialist or AIM-focused investor with a high tolerance for share-price volatility, a holding period of at least twelve to twenty-four months, and a willingness to accept sub-scale and integration risk in pursuit of a re-rating. The position should be sized as a satellite rather than a core holding, given the modest profitability profile (net margin of 4.41% as last publicly reported) and the dependence on a small number of large enterprise customers.
Avoid if: you require a meaningful dividend, cannot tolerate double-digit drawdowns on negative news flow, or need institutional-grade liquidity to build or exit a position cleanly. Conservative income investors and benchmark-relative managers with a low tolerance for small-cap AIM volatility should not hold this name, and any investor uncomfortable with the explicit scale and concentration risks disclosed in the issuer's own filings should also pass.
Recommendation
OPPORTUNISTIC BUY - 59/100. The tier reflects moderate upside to the published analyst target of 311p against the current 215p, offset by sub-scale economics, integration risk, and the absence of a hard near-term contract catalyst. The call would be upgraded to a higher conviction tier on disclosure of accelerating recurring revenue growth, a clean Enlighten integration update, or a named enterprise contract win. It would be downgraded on a negative trading update, evidence of customer churn in the financial-services vertical, or any indication that a dilutive capital raise is being prepared. At the current price of 89.00p the shares sit inside our buy zone (below 188.33p): the risk/reward on the scenario set clears our 2:1 threshold today.
The probability-weighted value across our three scenarios is 240.25p, 170% above the current price of 89.00p - the market has not yet priced our probability-weighted view. Levels below are derived from the scenario targets and probabilities above, not from percentage offsets to today's price.
below 188.33p - below this level the upside to the base-case target (245.00p) is at least 2x the downside to the bear case (160.00p), the minimum risk/reward we require before committing new capital.
between 188.33p and 245.00p - the base case is not yet fully priced, so existing holders are paid to wait, but new money gets no margin of safety in this zone.
above 245.00p - at this level the base case is fully reflected in the price and anything beyond it is paying for a bull scenario we weight at 25%.
if A full-year results announcement that discloses decelerating recurring revenue growth combined with a further rise in restructuring or integration costs, or a confirmed dilutive equity raise to fund the Enlighten integration, would invalidate the thesis, regardless of price - the bear target of 160.00p is the backstop, not an arbitrary percentage stop.
Conviction Trend
Latest conviction: 59/100. Trend versus prior report: Initiation.
| Report date | Conviction |
|---|---|
| 2026-10-04 | 59 |
Sources
Market data: DYOR HQ proprietary market data workflow.
Public sentiment and news flow: Coverage was drawn from public news flow, regulatory announcements filed via the London Stock Exchange and InvestEgate, publicly reported PDMR dealing disclosures, and analyst commentary aggregated on third-party financial research sites. No retail forum or stock-promoter commentary was relied upon.
Primary source types: Regulatory announcements (RNS / London Stock Exchange), company press releases, the ActiveOps investor relations site, full-year trading updates, and third-party equity research aggregation. The conviction and sentiment framework reflects a synthesis of these public materials rather than any single source.
Key sources
- ActiveOps Plc Share Price (AOM) - Stock London S.E. - MarketScreener UK
- ActiveOps Plc (AOM.L) Analyst Ratings, Estimates & Forecasts - Yahoo Finance
- ActiveOps Plc (AOM.L) Stock Price, News, Quote & History - Yahoo Finance
- ACTIVEOPS PLC AOM Stock | London Stock Exchange
- AOM: ActiveOps plc Stock Price Quote - London - Bloomberg
- ActiveOps (AOM) Investor Relations, Earnings Summary & Outlook
- 27 November 2025 ActiveOps Plc ("ActiveOps", "the Company", "the Group")
- ActiveOps (AIM:AOM) - Stock Analysis - Simply Wall St
- ActiveOps Plc News - AOM | ADVFN
- ActiveOps PLC Notification of Major Holdings - ADVFN
Analysis generated 2026-10-04. Market data as of 2026-11-13.